Abstract
Posaconazole (PSZ) is a BCS (biopharmaceutical classification system) Class II anti-fungal drug used to treat infections in immunocompromised patients. The work presented herein describes the generation of cocrystals of PSZ with 4-aminobenzoic acid (4AMB) using supercritical CO2 as an antisolvent in GAS (Gas Antisolvent) with acetonitrile, and as a solvent in CSS (Cocrystallization with Supercritical Solvent) methods. Cocrystals of PSZ-4AMB were obtained in a 2:3 stoichiometric ratio for the first time by GAS and CSS methods, with GAS producing higher-purity samples compared to CSS method. The work presented herein investigates the influence of critical processing variables using CO2 solvent and antisolvent crystallization methods with respect to the formation of cocrystals of PSZ-4AMB. A Design of Experiments (DoE) approach was performed to assess the outcome of PSZ-4AMB formation, impacted by processing variables such as pressure, temperature, and stirring rate using GAS and CSS methods. The resulting cocrystalline phase was identified using differential scanning calorimetry (DSC) and powder X-ray diffraction (PXRD). The particle morphologies and size distributions were determined using scanning electron microscopy and automated static imaging, respectively.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.